Tumor Necrosis Factor blockade in patients with Rheumatoid Arthritis inhibits Atherothrombosis.
Completed
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NL-OMON29079
- Lead Sponsor
- Academic Medical CenterAmsterdam, the Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
1. Male or female patients who were priorly diagnosed with RA, who are currently experiencing an inflammatory episode and who will be treated with TNF-alpha blockade;
2. Age 18-80 years.
Exclusion Criteria
1. Patients who were priorly diagnosed with diabetes, hypertension or cardiovascular disease;
2. Current signs or symptoms of severe, progressive or uncontrolled hepatic, haematological, gastroenterological, endocrine, pulmonary, cardiac or neurological disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method